Peptide Database
Showing 58 of 58 peptides
| Actions | |||||
|---|---|---|---|---|---|
| 5-amino-1MQFat loss, metabolic health, NNMT inhibition | Weight Loss | ANIMAL | Not Approved | 0 trial pubs0 registered4 PubMed references | |
| AOD-9604Fat metabolism, weight loss, cartilage repair | Weight Loss | PRECLINICAL | Category 2 | 0 trial pubs0 registered11 PubMed references | |
| ARA-290Neuropathic pain, diabetic neuropathy, tissue repair without erythropoiesis | Tissue Repair | PHASE II | Not Approved | 3 trial pubs4 registered23 PubMed references | |
| BPC-157Injury recovery, gut healing, tendon and ligament repair | Tissue Repair | PHASE II | Category 2 | 0 trial pubs2 registered203 PubMed references | |
| CagrilintideWeight loss, amylin analog, combined with semaglutide | Weight Loss | PHASE III | Not Approved | 8 trial pubs42 registered72 PubMed references | |
| CerebrolysinNeuroprotection, stroke recovery, dementia, TBI | Cognitive | APPROVED | Not Approved | 91 trial pubs42 registered624 PubMed references | |
| CJC-1295 with DACLong-acting GH elevation, less frequent dosing, sustained IGF-1 increase | Growth Hormone | PHASE II | Not Approved | 2 trial pubs1 registered29 PubMed references | |
| CJC-1295/IpamorelinGrowth hormone release, body composition, anti-aging | Growth Hormone | PHASE II | Not Approved | N/A trial pubs2 registered0 PubMed references | |
| DihexaCognitive enhancement, synaptogenesis, HGF/c-Met agonist | Cognitive | ANIMAL | Not Approved | 0 trial pubs0 registered17 PubMed references | |
| DSIPSleep quality, stress reduction, pain modulation | Sleep | ANIMAL | Not Approved | 15 trial pubs0 registered346 PubMed references | |
| EpithalonTelomerase activation, anti-aging, pineal gland function | Anti-Aging | APPROVED | Not Approved | 7 trial pubs0 registered189 PubMed references | |
| Follistatin-344Myostatin inhibition, muscle growth, muscular dystrophy research | Growth Hormone | PHASE I | Not Approved | 0 trial pubs1 registered5 PubMed references | |
| FOXO4-DRISenolytic, eliminates senescent cells, anti-aging | Anti-Aging | ANIMAL | Not Approved | 0 trial pubs0 registered17 PubMed references | |
| GHKSkin rejuvenation, gene expression reset, collagen synthesis, the base peptide behind GHK-Cu | Skin & HairAnti-Aging | ANIMAL | Not Approved | 1 trial pubsN/A registered250 PubMed references | |
| GHK-Cu (Copper Peptide)Skin rejuvenation, wound healing, collagen synthesis, hair growth | Skin & HairTissue Repair | PHASE II | Not Approved | 1 trial pubs1 registered152 PubMed references | |
| GHRP-2Potent GH release, appetite stimulation, body composition | Growth Hormone | ANIMAL | Not Approved | 56 trial pubs0 registered203 PubMed references | |
| GHRP-6Growth hormone release, appetite stimulation, gut motility | Growth Hormone | ANIMAL | Not Approved | 43 trial pubs0 registered632 PubMed references | |
| GlowSkin health, tissue repair, cosmetic blend | Skin & Hair | ANIMAL | Not Approved | N/A trial pubsN/A registered0 PubMed references | |
| HCGFertility treatment, testosterone support, hormone regulation | Hormonal | APPROVED | Approved | 725 trial pubs394 registered16,889 PubMed references | |
| HexarelinMost potent GHRP, cardioprotective effects, GH secretion research | Growth Hormone | ANIMAL | Not Approved | 58 trial pubs0 registered288 PubMed references | |
| HGHGrowth hormone deficiency, anti-aging, body composition | Growth Hormone | APPROVED | Approved | 946 trial pubs812 registered9,318 PubMed references | |
| HumaninCytoprotection, neuroprotection, metabolic health | Anti-Aging | ANIMAL | Not Approved | 7 trial pubs2 registered517 PubMed references | |
| IGF-1 LR3Muscle protein synthesis, extended half-life IGF-1, anabolic | Growth Hormone | ANIMAL | Not Approved | 0 trial pubs0 registered10 PubMed references | |
| IpamorelinSelective growth hormone release, body composition, sleep quality | Growth Hormone | PHASE II | Not Approved | 2 trial pubs2 registered46 PubMed references | |
| KisspeptinFertility treatment, hormone optimization, GnRH regulation, reproductive health | Hormonal | PHASE III | Not Approved | 60 trial pubs36 registered3,223 PubMed references | |
| KPVAnti-inflammatory, gut health, IBD research | ImmuneTissue Repair | ANIMAL | Not Approved | 0 trial pubs0 registered65 PubMed references | |
| LiraglutideWeight loss, type 2 diabetes, cardiovascular protection | Weight Loss | APPROVED | Approved | 606 trial pubs510 registered5,328 PubMed references | |
| LL-37Antimicrobial, immune modulation, wound healing | ImmuneTissue Repair | PHASE III | Not Approved | 58 trial pubs20 registered2,458 PubMed references | |
| MazdutideWeight loss, dual GLP-1/glucagon agonist, Chinese-developed obesity drug | Weight Loss | PHASE III | Investigational | 6 trial pubs31 registered38 PubMed references | |
| Melanotan 2Tanning, sexual function, appetite suppression | Skin & HairSexual Health | PHASE II | Not Approved | 4 trial pubs1 registered197 PubMed references | |
| Melanotan ISkin tanning, photoprotection, erythropoietic protoporphyria (EPP) | Skin & Hair | APPROVED | Approved | 12 trial pubs23 registered292 PubMed references | |
| MK-677 (Ibutamoren)Oral GH secretagogue, sleep quality, muscle preservation | Growth Hormone | PHASE III | Not Approved | 19 trial pubs8 registered114 PubMed references | |
| MOTS-cExercise mimetic, metabolic health, insulin sensitivity | Anti-Aging | PHASE II | Not Approved | 5 trial pubs4 registered231 PubMed references | |
| NA-Semax AmidateEnhanced cognitive version of Semax, longer-acting, BDNF stimulation | Cognitive | APPROVED | Not Approved | 0 trial pubs0 registered0 PubMed references | |
| NAD+Cellular energy, DNA repair, anti-aging, sirtuin activation | Anti-Aging | ANIMAL | Not Approved | 233 trial pubsN/A registered46,065 PubMed references | |
| OxytocinSocial bonding, anxiety, trust, autism research, childbirth | Hormonal | APPROVED | Approved | 2,384 trial pubs913 registered28,903 PubMed references | |
| PinealonNeuroprotection, sleep regulation, cognitive enhancement, Khavinson bioregulator | CognitiveSleep | APPROVED | Not Approved | 1 trial pubs0 registered15 PubMed references | |
| PT-141 (Bremelanotide)Sexual dysfunction, FDA-approved for HSDD, melanocortin agonist | Sexual Health | APPROVED | Approved | 16 trial pubs10 registered107 PubMed references | |
| PTD-DBMHair growth, androgenetic alopecia, Wnt pathway activation, topical hair peptide | Skin & Hair | PRECLINICAL | Not Approved | 0 trial pubs0 registered4 PubMed references | |
| RetatrutideWeight loss, triple agonist (GLP-1/GIP/glucagon) | Weight Loss | PHASE III | Not Approved | 6 trial pubs32 registered133 PubMed references | |
| SelankAnxiety reduction, cognitive enhancement, immune modulation | Cognitive | APPROVED | Not Approved | 3 trial pubs2 registered68 PubMed references | |
| SemaglutideWeight loss, type 2 diabetes, cardiovascular risk reduction | Weight Loss | APPROVED | Approved | 284 trial pubs686 registered4,535 PubMed references | |
| SemaxCognitive enhancement, neuroprotection, stroke recovery | Cognitive | APPROVED | Not Approved | 4 trial pubs0 registered203 PubMed references | |
| SermorelinGrowth hormone stimulation, sleep quality, anti-aging | Growth Hormone | APPROVED | Not Approved | 0 trial pubs27 registered22 PubMed references | |
| SLU-PP-332Exercise mimetic, ERR-alpha agonist, endurance research | Other | ANIMAL | Not Approved | 0 trial pubs0 registered10 PubMed references | |
| SNAP-8Anti-wrinkle, topical Botox alternative, expression line reduction | Skin & Hair | PRECLINICAL | Not Approved | 0 trial pubs0 registered0 PubMed references | |
| SS-31 (Elamipretide)Mitochondrial function, anti-aging, cardiac protection | Anti-Aging | APPROVED | Not Approved | 22 trial pubs26 registered435 PubMed references | |
| SurvodutideWeight loss, MASH/NASH liver disease, dual GLP-1/glucagon agonist | Weight Loss | PHASE III | Investigational | 7 trial pubs24 registered60 PubMed references | |
| TB 500Tissue repair, wound healing, muscle recovery | Tissue Repair | PHASE II | Category 2 | 0 trial pubs1 registered16 PubMed references | |
| TelmisartanBlood pressure, metabolic syndrome, PPAR-delta activation | OtherHormonal | APPROVED | Approved | 503 trial pubs347 registered2,938 PubMed references | |
| TesamorelinVisceral fat reduction, growth hormone deficiency, lipodystrophy | Growth HormoneWeight Loss | APPROVED | Approved | 23 trial pubs24 registered87 PubMed references | |
| TesofensineWeight loss, triple monoamine reuptake inhibitor, appetite suppression | Weight Loss | PHASE II | Investigational | 11 trial pubs13 registered51 PubMed references | |
| ThymalinImmune restoration, thymus rejuvenation, longevity research, Khavinson bioregulator | ImmuneAnti-Aging | APPROVED | Not Approved | 12 trial pubs0 registered234 PubMed references | |
| Thymosin Alpha-1Immune modulation, T-cell function, hepatitis treatment | Immune | APPROVED | Not Approved | 49 trial pubs61 registered575 PubMed references | |
| Thymosin Beta-4Full-length healing peptide, wound repair, cardiac repair, more complete than TB-500 | Tissue Repair | PHASE III | Category 2 | 3 trial pubs18 registered593 PubMed references | |
| TirzepatideWeight loss, type 2 diabetes, dual GIP/GLP-1 agonist | Weight Loss | APPROVED | Approved | 122 trial pubs236 registered1,942 PubMed references | |
| TrevogrumabMyostatin blocker, anti-muscle-loss for GLP-1 users, Regeneron antibody | Growth Hormone | PHASE II | Investigational | 0 trial pubs1 registered2 PubMed references | |
| VIPCIRS/mold illness (Shoemaker protocol), pulmonary hypertension, neuroinflammation | Immune | ANIMAL | Not Approved | 112 trial pubsN/A registered8,347 PubMed references |